-
Bendamustine has received FDA approval, after priority review, for the treatment of chronic lymphocytic leukemia.
-
A statistically significant improvement in symptoms was observed in the treatment groups, with the honey-child group scoring the best, and the no treatment group doing the most poorly.
-
Mild TBI may be associated with brain microhemorrhages and white matter disruption, even with mild or absent symptoms of a postconcussion syndrome.
-
The proton pump inhibitor rabeprazole is said to provide rapid acid inhibition, but clinical implications of this have been uncertain. This study shows that a single dose of rabeprazole 20 mg administered 5 hours before therapeutic dosing of aspirin significantly decreases gastroduodenal damage.
-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
-
Chronic wounds represent a significant portion of the complaints seen by physicians, especially in the primary care setting. Visits for wound care account for just over 2% of all visits to office-based physicians in the United States.
-
-
Simultaneously recorded leads II and MCL1 rhythm strip obtained from a middle-aged adult with heart disease. Despite this "run of VT", the patient remained alert, hemodynamically stable, and asymptomatic during tachycardia.
-
A second somatostatin (growth hormone inhibiting hormone) analog is available for the long-term treatment of acromegaly in patients who have not responded to other treatment modalities.